3/4/2026 – Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
12/16/2025 – From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes